Among the genes controlled in both LUSC and LUAD, we found BCL9L, a member of the Wnt pathway54 with known oncogenic activities in multiple cancer types, including colon adenocarcinomas23, hepatocellular carcinomas24 and pancreatic adenocarcinomas25. This evidence concerns the gene BCL9L and cancer.